International Journal of Dental Sciences and Research
ISSN (Print): 2333-1135 ISSN (Online): 2333-1259 Website: Editor-in-chief: Apply for this position
Open Access
Journal Browser
International Journal of Dental Sciences and Research. 2015, 3(6), 124-127
DOI: 10.12691/ijdsr-3-6-1
Open AccessArticle

Preparation of Ketamine Powder from Ketamine Hydrochloride and Study Their Physicochemical Properties

Amer A. Taqa1, , Ghada A. Taqa1 and Banan N. Al-Hussary1

1Department of Dental Basic Sciences, College of Dentistry, University of Mosul,Mosul, Iraq

Pub. Date: January 11, 2016

Cite this paper:
Amer A. Taqa, Ghada A. Taqa and Banan N. Al-Hussary. Preparation of Ketamine Powder from Ketamine Hydrochloride and Study Their Physicochemical Properties. International Journal of Dental Sciences and Research. 2015; 3(6):124-127. doi: 10.12691/ijdsr-3-6-1


The aim of the present study was extract pure ketamine powder from ketamine hydrochloride solution. Different concentrations of ketamine gel were prepared. Materials and methods: Ketamine powder was prepared from precipitation of ketamine hydrochloride solution and characterized by Infrared Spectroscopy (IR), Ultraviolet (UV), Micro elemental analysis (CHN) analysis, and measurement of melting point. Homogeneous gel from ketamine was prepared at (0.5, 1, 5, 10, and 15) % concentrations. The pH of the different concentrations of the ketamine gel also were measured. The results demonstrated that Ultraviolet (UV) spectra showed bands at 228, 268, 294 nm which confirm the groups in the ketamine structure. The CHN analysis showed that no difference between the theoretical calculated and practical percentage of the prepared ketamine powder. The pH ketamine gel measurement showed that there is no difference between pH in different concentration.

ketamine powder ketamine gel FTIR UV CHN

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


Figure of 5


[1]  Curtero M, carrie H, malic U, Romic U' Tatios B, Wu M (2006). “Acomparision of frequently prescribed analgesics at the university of Toronto for post operative pain following dental surgery”. anevidancer-based study of the literature. community dentistry 1:1-12.
[2]  Dahl V and Reader JC (2000). “Non-opioid postoperative analgesia”. J.ActaAnaesthesiol Scand.; 44:1191- 1203.
[3]  Babar A, Solanki UD, Cutie AJ, Plakogiannis F (1990). “Piroxicam release from dermatological bases: in vitro studies using cellulose membrane and hairless mouse skin”. Drug DevInd Pharm 16: 523-540.
[4]  Alarcon E, (2002). “A comparative study of the transdermal penetration of a series of non-steroidal anti-inflammatory drugs”. J. of pharmacenticalscinces, 86; (24)503-308.
[5]  Daniels R, KnieU, (2007). “Galenics of dermal product, vehicles , properties and drug release”. JDDG .; 5 : 367-38.
[6]  Orser BA, Pennefather PS, and MacDonald JF (1997). “Multiple mechanisms of ketamine blockade of Nmethyl-D-aspartate receptors”. Anesthesiology; 86:903-917.
[7]  Peck TE, Hill SA, Williams M (2008). “Pharmacology for anaesthesia and intensive care”. Cambridge: Cambridge university press. p. 111.
[8]  Roewer N, Thiel H (2003).”Flammarion”. Atlas de poched’anesthésie. Paris.
[9]  Schorderet M (1998). “Pharmacologie: des concepts fondamentaux aux applications thérapeutiques”. 3rd ed. Paris, Genève: Frison-Roche, Slatkine.
[10]  Annetta MG, Iemma D, Garisto C, (2005). “Ketamine:new indications for an old drug”. Curr Drug Targets6(7):789-94.
[11]  Griffiths W (2003). “Formulating IV drugs for neonatal intensive care” Hosp Pharm Eur; 10:78-80.
[12]  Qye I, Paulsen O and Maurset A (1992). “Effects of ketamine on sensory perception: Evidence for a role of N-methyl-D-aspartate receptors”. J. PharmacolExpTher 260:1209-1213.
[13]  Patricia K. Morley-F, Rajarathinam M, Craig R, Bradley U, David F (2009). “UPTAKE OF TOPICAL 10% KETAMINE GEL OVER 7 DAYS “. Pain; 146:18-25.
[14]  Mario J, Mira B.L., Biserka C.C. (2005). “Influence of Cyclodextrin Complexation on Piroxicam Gel Formulaion”. ActaPharma; 55: 223-236.
[15]  Illum L, Farraj N F, Davis S (1994). “Chitosan as a novel nasal delivery system for peptide drugs”. Pharm. Res.; 11:1186-9.